IP Library Assignment 069628/0761
Patent Assignment
Reel/Frame 069628/0761

Assignment of Assignor's Interest

Recorded: 2024-12-18 Pages: 19
Assignors
REGOR PHARMACEUTICALS, INC.
Executed: 2024-11-09
QILU REGOR THERAPEUTICS INC.
Executed: 2024-11-09
Assignee
GENENTECH, INC.
1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-4990
Covered Properties (5)
Cdk Inhibitors
Application: 17/922,804 →
Publication: US 2023/0174512
Cdk Inhibitors
Application: 18/373,060 →
Publication: US 2024/0066031
Cdk Inhibitors
Application: 18/373,067 →
Publication: US 2024/0033264
Cdk Inhibitors
Application: 18/785,844 →
Publication: US 2025/0064806
Cdk Inhibitors
Application: 17/608,915 →
Publication: US 2022/0296595
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 5, 2022
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHU, XIAOTIAN
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 058556/0566 →
Assignment of Assignor's Interest Dec 1, 2022
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHONG, WENGE
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 061942/0221 →
Assignment of Assignor's Interest Oct 24, 2023
From: QILU REGOR THERAPEUTICS INC.
To: REGOR PHARMACEUTICALS, INC.
Reel/Frame 065322/0727 →
Assignment of Assignor's Interest Oct 26, 2023
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHU, XIAOTIAN
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 065353/0465 →
Assignment of Assignor's Interest Oct 26, 2023
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHU, XIAOTIAN
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 065353/0529 →
Assignment of Assignor's Interest Aug 26, 2024
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHONG, WENGE
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 068397/0095 →
Assignment of Assignor's Interest Aug 28, 2024
From: QILU REGOR THERAPEUTICS INC.
To: REGOR PHARMACEUTICALS, INC.
Reel/Frame 068427/0733 →
Assignment of Assignor's Interest Jan 7, 2025
From: HU, ZHILONG; HE, HU; ZHANG, FEI; ZHONG, WENGE
To: QILU REGOR THERAPEUTICS INC.
Reel/Frame 069768/0111 →
Assignment of Assignor's Interest Jan 7, 2025
From: REGOR PHARMACEUTICALS, INC.; QILU REGOR THERAPEUTICS INC.
To: GENENTECH, INC.
Reel/Frame 069768/0818 →